TKG (Drug Discovery) Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 8

TKG (Drug Discovery) General Information

Description

Developer of cancer immunotherapy drugs designed to induce innate immunity. The company specializes in using hairpin-shaped nucleic acid drugs and miRNA that is specifically overexpressed in cancer cells as a biomarker, forming a nucleic acid aggregate that is recognized as a foreign substance inside target disease cells, triggering innate immunity and leading to the death of cancer cells, enabling clients to help patients develop selectively stronger immunity against certain carcinogenic substances and against cancer cells.

Contact Information

Website
www.tkg-na.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Entrepreneur Lab, South Research Building The University of Tokyo
  • 7-3-1 Hongo, Bunkyo-ku
  • Tokyo, Bunkyo-ku 113-8485
  • Japan
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Entrepreneur Lab, South Research Building The University of Tokyo
  • 7-3-1 Hongo, Bunkyo-ku
  • Tokyo, Bunkyo-ku 113-8485
  • Japan

TKG (Drug Discovery) Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TKG (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Accelerator/Incubator 01-Jun-2025 Completed Generating Revenue
7. Seed Round 31-Jan-2024 Completed Generating Revenue
6. Accelerator/Incubator 13-Sep-2023 Completed Startup
5. Debt - General 23-Jun-2023 Completed Startup
4. Accelerator/Incubator 01-Jan-2023 Completed Startup
3. Accelerator/Incubator Completed Startup
2. Accelerator/Incubator 01-Jan-2023 Completed Startup
1. University Spin-Out 01-Apr-2022 Completed Startup
To view TKG (Drug Discovery)’s complete valuation and funding history, request access »

TKG (Drug Discovery) Patents

TKG (Drug Discovery) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025257997-A1 Method for synthesizing oligo- or poly-nucleotides Pending 12-Jun-2024
JP-2025022473-A Method for extracting nucleic acid, composition, and cosmetic composition Pending 03-Aug-2023
JP-2024149267-A Method for synthesizing oligo- or polynucleotides Pending 07-Apr-2023
JP-2024138694-A Method for producing hairpin nucleic acid Pending 27-Mar-2023
US-20260232716-A1 Nucleic acid assembly pharmaceutical Pending 07-Feb-2023 A61K31/7125
To view TKG (Drug Discovery)’s complete patent history, request access »

TKG (Drug Discovery) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TKG (Drug Discovery) Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Plug and Play Accelerator/Incubator
Mitsubishi Gas Chemical Corporation Minority
UntroD Venture Capital Minority
Japan External Trade Organization Accelerator/Incubator
G-STARTUP Accelerator/Incubator
You’re viewing 5 of 8 investors. Get the full list »

TKG (Drug Discovery) FAQs

  • When was TKG (Drug Discovery) founded?

    TKG (Drug Discovery) was founded in 2022.

  • Where is TKG (Drug Discovery) headquartered?

    TKG (Drug Discovery) is headquartered in Tokyo, Japan.

  • What is the size of TKG (Drug Discovery)?

    TKG (Drug Discovery) has 2 total employees.

  • What industry is TKG (Drug Discovery) in?

    TKG (Drug Discovery)’s primary industry is Drug Discovery.

  • Is TKG (Drug Discovery) a private or public company?

    TKG (Drug Discovery) is a Private company.

  • What is TKG (Drug Discovery)’s current revenue?

    The current revenue for TKG (Drug Discovery) is .

  • How much funding has TKG (Drug Discovery) raised over time?

    TKG (Drug Discovery) has raised $1.53M.

  • Who are TKG (Drug Discovery)’s investors?

    Plug and Play, Mitsubishi Gas Chemical, UntroD, Japan External Trade Organization, and G-STARTUP are 5 of 8 investors who have invested in TKG (Drug Discovery).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process